| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5351c62aee4203f2be2944f21a6def2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-314 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 |
| filingDate |
2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4581be9d796dc3d0639839ea3d252a7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12327481669309c759a345a2e7c803df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b45c28f90c0e03662632ce4ba7c65bd4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21101184ca71442baaef87050a7d3cce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd1dfaee3dbcf2689faf39304d94d5d3 |
| publicationDate |
2020-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020175817-A1 |
| titleOfInvention |
Composition for preventing, ameliorating, or treating fibrosis |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating fibrosis. A composition comprising a compound represented by chemical formula 1 of the present invention as an active ingredient can be used very effectively for the prevention or treatment of fibrosis by inhibiting the expression or activity of histone acetyltransferases. Furthermore, since the compound represented by chemical formula 1 of the present invention specifically inhibits only p300 among various histone acetyltransferases, the compound does not affect other acetylating enzymes that play an important role in the maintenance of life, and thus can reduce side effects that may occur when preventing or treating fibrosis. |
| priorityDate |
2019-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |